Countries around the globe are embracing legal medicinal or recreational cannabis, and the industry is reacting accordingly.
Tag Archives: Cowen and Company
KELOWNA, British Columbia, April 28, 2017 /Weed Wire/ — Marapharm Ventures Inc. (OTCQB: MRPHF) is pleased to announce that it will be launching http://www.marapharm.tv on or before June 15, 2017.
Medical cannabis was in demand in California this past 420 holiday. According to Onfleet, a delivery management company, medical cannabis delivery in The Golden State spiked to great heights on April 20.
On April 20, 2017, Cowen and Company, a leading Wall Street investment bank, issued a report that shows the accelerated adoption of cannabis pressuring alcohol volumes, with beer most at risk.
LOS ANGELES, Jan. 30, 2016 /Weed Wire/ — Adam Bierman, co-founder and chief executive of Los Angeles-based cannabis firm MedMen, has been tapped by the industry’s top trade organization to help lead its efforts in shaping federal marijuana policy.
LOS ANGELES, Jan. 27, 2017 /Weed Wire/ — Despite major strides in legalization at the state level, illicit trade still accounts for nearly 90 percent of U.S. cannabis sales on average, according to a recent report on the state of the cannabis industry in North America.
LOS ANGELES, Jan. 20, 2017 /Weed Wire/ — “On a bustling stretch of Santa Monica Boulevard lined by vintage stores and eateries, the MedMen shop looks right at home,” the Los Angeles Times proclaimed in a front-page article this week headlined “For Pot Shops, a Whiff of Luxury.”
Kush Bottles, Inc. (OTCQB: KSHB), a leading provider of packaging supplies, accessories and branding solutions for the regulated cannabis industry, has been invited to participate in Cowen’s Cannabis Colloquium which is being held in New York City on January 12, 2017.
SMITH FALLS, Ontario, Dec. 22, 2016 /Weed Wire/ — Canopy Growth Corporation (TSX: CGC) (“Canopy Growth” or the “Company”) announced that it has closed its previously announced short form prospectus offering on a bought deal basis.
According to a report by the equity research firm Cowen & Co., marijuana will generate $50 billion in revenue by 2026. That’s roughly eight times the estimated revenue this year. GW Pharmaceuticals and Insys Therapeutics are two big companies with an even bigger future.
According to a recent report from Cowen and Company, the legalization of cannabis is starting to affect beer volumes in Colorado, Oregon and Washington.
On Sept. 12, 2016, Cowen and Company (Nasdaq:COWN) released a report on the near- and long-term market potential of legal recreational cannabis in the United States, estimating that a federally legal U.S. cannabis market could reach $50 billion in gross retail sales by 2026.